Latest / Oncology Data Advisor
Additional Insights in Dedifferentiated Liposarcoma With Richard F. Riedel, MD, and Candace L. Haddox, MD
As research in dedifferentiated liposarcoma (DDLPS) continues to advance, the importance of multidisciplinary collaboration and access to innovative therapies remains at the forefront of patient care. Recently, Dr. Richard Riedel of Duke Cancer Institute and Dr. Candace Haddox of Dana-Farber Cancer Institute co-chaired i3 Health’s DDLPS Task Force activity, which brought together a panel of experts to address the complexities of this rare and challenging sarcoma subtype. With new clinical trials underway and a growing understanding of the disease’s molecular landscape, Dr. Riedel and Dr…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.